Braf Mutation As A Prognostic Marker For Survival In Malignant Melanoma: A Systematic Review And Meta-Analysis.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 13|浏览9
暂无评分
摘要
e21566Background: BRAF mutation analysis has become increasingly common in the diagnosis of cutaneous melanoma and BRAF inhibitors constitute a cornerstone in the treatment of metastatic disease. H...
更多
查看译文
关键词
malignant melanoma,mutation,prognostic marker,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要